Literature DB >> 16415193

Novel anti-inflammatory effect of statins: reduction of CD4+CD28null T lymphocyte frequency in patients with unstable angina.

S Brugaletta, L M Biasucci, M Pinnelli, G Biondi-Zoccai, G Di Giannuario, G Trotta, G Liuzzo, F Crea.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16415193      PMCID： PMC1860749          DOI： 10.1136/hrt.2004.052282

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  6 in total

1.  T-cell-mediated lysis of endothelial cells in acute coronary syndromes.

Authors:  Takako Nakajima; Stephanie Schulte; Kenneth J Warrington; Stephen L Kopecky; Robert L Frye; Jörg J Goronzy; Cornelia M Weyand
Journal:  Circulation       Date:  2002-02-05       Impact factor: 29.690

2.  CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity.

Authors:  D Schmidt; J J Goronzy; C M Weyand
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

3.  Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes.

Authors:  G Liuzzo; J J Goronzy; H Yang; S L Kopecky; D R Holmes; R L Frye; C M Weyand
Journal:  Circulation       Date:  2000-06-27       Impact factor: 29.690

Review 4.  Atherosclerosis: anti-inflammatory and immunomodulatory activities of statins.

Authors:  Brenda R Kwak; Flore Mulhaupt; François Mach
Journal:  Autoimmun Rev       Date:  2003-10       Impact factor: 9.754

5.  Inhibition of hydroxymethylglutaryl-coenzyme a reductase reduces Th1 development and promotes Th2 development.

Authors:  Rie Hakamada-Taguchi; Yoshio Uehara; Kagemasa Kuribayashi; Atsushi Numabe; Kanako Saito; Hideyuki Negoro; Toshiro Fujita; Teruhiko Toyo-oka; Takuma Kato
Journal:  Circ Res       Date:  2003-10-16       Impact factor: 17.367

6.  Heat-shock protein 60-reactive CD4+CD28null T cells in patients with acute coronary syndromes.

Authors:  Behnam Zal; Juan Carlos Kaski; Gavin Arno; Julius P Akiyu; Qingbo Xu; Della Cole; Michael Whelan; Nick Russell; J Alejandro Madrigal; I Anthony Dodi; Christina Baboonian
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690
  6 in total
  18 in total

Review 1.  Targeting inflammation: impact on atherothrombosis.

Authors:  Maria Giulia Marini; Chiara Sonnino; Marco Previtero; Luigi M Biasucci
Journal:  J Cardiovasc Transl Res       Date:  2013-12-11       Impact factor: 4.132

Review 2.  Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential.

Authors:  Charlotte Spitz; Holger Winkels; Christina Bürger; Christian Weber; Esther Lutgens; Göran K Hansson; Norbert Gerdes
Journal:  Cell Mol Life Sci       Date:  2015-10-30       Impact factor: 9.261

3.  Peripheral and site-specific CD4(+) CD28(null) T cells from rheumatoid arthritis patients show distinct characteristics.

Authors:  J Pieper; S Johansson; O Snir; L Linton; M Rieck; J H Buckner; O Winqvist; R van Vollenhoven; V Malmström
Journal:  Scand J Immunol       Date:  2014-02       Impact factor: 3.487

Review 4.  T cell senescence and cardiovascular diseases.

Authors:  Hee Tae Yu; Sungha Park; Eui-Cheol Shin; Won-Woo Lee
Journal:  Clin Exp Med       Date:  2015-07-19       Impact factor: 3.984

5.  Rosuvastatin induces apoptosis in CD4(+)CD28 (null) T cells in patients with acute coronary syndromes.

Authors:  Andreas Link; Simina Selejan; Lisa Hewera; Felix Walter; Georg Nickenig; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2010-09-19       Impact factor: 5.460

Review 6.  The life (and death) of CD4+ CD28(null) T cells in inflammatory diseases.

Authors:  Ingrid E Dumitriu
Journal:  Immunology       Date:  2015-09-07       Impact factor: 7.397

Review 7.  Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective.

Authors:  Richard Kones
Journal:  Drug Des Devel Ther       Date:  2010-12-09       Impact factor: 4.162

8.  Apoptotic effects of antilymphocyte globulins on human pro-inflammatory CD4+CD28- T-cells.

Authors:  Christina Duftner; Christian Dejaco; Paul Hengster; Klaudija Bijuklic; Michael Joannidis; Raimund Margreiter; Michael Schirmer
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

Review 9.  The story of CD4+ CD28- T cells revisited: solved or still ongoing?

Authors:  Kathrin Maly; Michael Schirmer
Journal:  J Immunol Res       Date:  2015-03-05       Impact factor: 4.818

10.  Circulating CD4(+)CD28null T Cells May Increase the Risk of an Atherosclerotic Vascular Event Shortly after Kidney Transplantation.

Authors:  Michiel G H Betjes; Willem Weimar; Nicolle H R Litjens
Journal:  J Transplant       Date:  2013-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.